GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

Search

Haleon PLC

Chiusa

SettoreSettore sanitario

343.7 1.06

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

341.1

Massimo

343.8

Metriche Chiave

By Trading Economics

Entrata

403M

Vendite

2.7B

P/E

Media del settore

17.216

51.415

EPS

0.044

Rendimento da dividendi

2.14

Margine di Profitto

14.708

Dipendenti

24,535

EBITDA

697M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+29.65% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

2.14%

2.34%

Utili prossimi

30 lug 2026

Prossima data del' Ex Dividendo

13 ago 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

29B

Apertura precedente

342.64

Chiusura precedente

343.7

Notizie sul Sentiment di mercato

By Acuity

46%

54%

144 / 345 Classifica in Healthcare

Haleon PLC Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

29 apr 2026, 07:48 UTC

Utili

Sensodyne-Maker Haleon Revenue Rises on Oral Health Growth -- Update

29 apr 2026, 06:39 UTC

Utili

Sensodyne-maker Haleon Revenue Rises on Oral Health Growth

25 feb 2026, 07:55 UTC

Utili

Panadol Maker Haleon Reports Revenue Slowdown Amid Weak Cold-And-Flu Season

29 apr 2026, 08:05 UTC

Discorsi di Mercato
Utili

Haleon's North America Results Were Encouraging -- Market Talk

29 apr 2026, 07:46 UTC

Discorsi di Mercato
Utili

Haleon's First-Quarter Results Align With Peers -- Market Talk

29 apr 2026, 06:07 UTC

Utili

Haleon: 1Q Emerging Markets Revenue Growth 4.3%

29 apr 2026, 06:06 UTC

Utili

Haleon: Q1 North America Organic Revenue Growth 1.0%

29 apr 2026, 06:05 UTC

Utili

Haleon 1Q Reported Revenue Growth 0.1%

29 apr 2026, 06:04 UTC

Utili

Analysts Saw Haleon 1Q Organic Revenue Growth 2.3%

29 apr 2026, 06:04 UTC

Utili

Haleon 1Q Organic Revenue Growth 2.2%

29 apr 2026, 06:04 UTC

Utili

Haleon 1Q Rev GBP2.86B

29 apr 2026, 06:04 UTC

Utili

Haleon Sees High-single Digit Adjusted Operating Profit Growth at Constant Currency in Medium Term

29 apr 2026, 06:03 UTC

Utili

Haleon Sees 4% to 6% Organic Rev Growth in Medium Term

29 apr 2026, 06:03 UTC

Utili

Haleon Expects a Broadly Neutral Foreign Exchange Translation Impact on Net Rev, Adj Oper Pft

29 apr 2026, 06:02 UTC

Utili

Haleon Sees 2026 Adjusted Effective Tax Rate c.24.5%

29 apr 2026, 06:02 UTC

Utili

Haleon: Sees 2026 Net Interest GBP255 Million

29 apr 2026, 06:02 UTC

Utili

Haleon Sees 2026 High-single Digit Adj Oper Pft Growth at Constant Currency

29 apr 2026, 06:01 UTC

Utili

Haleon Sees 2026 Organic Revenue Growth 3% to 5%

25 feb 2026, 07:18 UTC

Utili

Haleon 4Q Organic Revenue Growth 2.1%

25 feb 2026, 07:17 UTC

Utili

Haleon: GBP500M Allocated to Share Buybacks in 2026

25 feb 2026, 07:16 UTC

Utili

Haleon Sees 2026 High Single Digit Adj. Operating Profit Growth at Constant Currency

25 feb 2026, 07:15 UTC

Utili

Haleon Sees 2026 Organic Revenue Growth of 3% to 5%

25 feb 2026, 07:06 UTC

Utili

Haleon Declares Final Dividend of 4.9p

25 feb 2026, 07:05 UTC

Utili

Haleon 2025 Net Pft GBP1.67B

25 feb 2026, 07:05 UTC

Utili

Haleon 2025 Pretax Pft GBP2.15B

25 feb 2026, 07:04 UTC

Utili

Analysts Saw Haleon 2025 Adj Oper Pft at GBP2.46B

25 feb 2026, 07:04 UTC

Utili

Analysts Saw Haleon 2025 Adj Oper Pft Margin at 22.3%

25 feb 2026, 07:04 UTC

Utili

Analysts Saw Haleon 2025 Organic Revenue Growth at 3.4%

25 feb 2026, 07:04 UTC

Utili

Analysts Saw Haleon 2025 Rev at GBP11.03B

25 feb 2026, 07:04 UTC

Utili

Haleon 2025 Adj. Operating Pft Margin 22.9%

Confronto tra pari

Modifica del prezzo

Haleon PLC Previsione

Obiettivo di Prezzo

By TipRanks

29.65% in crescita

Previsioni per 12 mesi

Media 426.67 GBX  29.65%

Alto 512 GBX

Basso 325 GBX

Basato su 10 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Haleon PLC - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

10 ratings

7

Acquista

2

Mantieni

1

Vendi

Sentiment

By Acuity

144 / 345 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
help-icon Live chat